Sojourn Liquid
Product Images NDC 66794-012

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sojourn (NDC 66794-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sevo Fig 3

A line graph titled 'Ratio of Concentration of Anesthetic in Alveolar Gas to Inspired Gas' depicting the Fa/Fi ratio over 30 minutes of administration for five anesthetics: Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O. The x-axis represents minutes of administration (0 to 30), and the y-axis represents the Fa/Fi ratio ranging from 0 to 1. Different symbols and line styles distinguish each anesthetic's concentration ratio progression over time.*

FDA Label Image

Sevo Fig 4

Line graph illustrating the concentration of anesthetic in alveolar gas following termination of anesthesia. The y-axis is labeled as the ratio F/FA0 on a logarithmic scale, and the x-axis represents minutes of elimination from 0 to 120. The graph compares elimination curves for Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O over time.*

FDA Label Image

Sevo Fig 5

A line graph showing serum inorganic fluoride concentrations over days post-anesthesia for five volatile anesthetics: Methoxyflurane, Sevoflurane, Enflurane, Isoflurane, and Halothane. The x-axis represents days post-anesthesia, and the y-axis shows serum fluoride levels in micromolar (µM). Sevoflurane shows the highest peak concentration among the anesthetics.*

FDA Label Image

Sevo Fig 7

A line graph titled 'Figure 7. Heart Rate' showing heart rate in beats per minute on the vertical axis and MAC level on the horizontal axis. It compares heart rates at baseline and different MAC levels for two groups: one receiving Sevoflurane with O2, and the other receiving Sevoflurane with O2 and N2O, represented by diamond and triangle symbols respectively.*

FDA Label Image

Sevo Fig 8

A line graph titled 'Mean Arterial Pressure' showing values in mmHg on the y-axis and MAC level on the x-axis. The graph compares two groups labeled as 'A – Sevo/O2' and 'C – Sevo/O2/N2O' at baseline and various MAC levels, with data points connected by lines and error bars representing variability.*

FDA Label Image

Sevofig1 (Sevo Fig1)

A line chart titled 'Fresh Gas Flow Rate versus Compound A Levels in a Circle Absorber System,' showing Compound A levels in ppm on the vertical axis and Fresh Gas Flow Rate in L/min on the horizontal axis. The graph depicts a decreasing trend in Compound A levels as Fresh Gas Flow Rate increases from 0.5 to 4 L/min, with data points marked by squares connected by lines.*

FDA Label Image

Sevo-fig10 (Sevo Fig10)

A line graph titled "Figure 10. Cardiac Index" showing cardiac index values (L/min/m²) on the vertical axis and MAC level on the horizontal axis. The graph compares two groups: A (Sevo/O2) represented by diamonds, and C (Sevo/O2/N2O) represented by triangles, with measurements at baseline and multiple MAC levels.*

FDA Label Image

Figure2 (Sevo Fig2)

A line graph titled "Figure 2: Carbon Dioxide Flow Versus Compound A and Maximum Temperature" showing the relationship between carbon dioxide flow (mL/min) on the x-axis and compound A concentration (ppm) or maximum temperature (°C) on the y-axis. Two lines are plotted: one with circular markers representing Compound A levels in ppm and another with square markers showing maximum temperature in degrees Celsius, both increasing as carbon dioxide flow increases.*

FDA Label Image

Figure2a (Sevo Fig2a)

A scatter plot with a regression line illustrating the relationship between inspired compound area under the curve (AUC) in ppm-hours and sevoflurane MAC-hours at a flow rate of 1 L/min. The x-axis represents sevoflurane (MAC-Hour), and the y-axis shows inspired compound AUC (ppm-hr). Correlation statistics (r = 0.96, p < 0.001) are included.*

FDA Label Image

Sevo-fig6 (Sevo Fig6)

Line graph showing mean fluoride ion concentrations over time following administration of Sevoflurane (mean MAC 1.27, mean duration 2.06 hours). The y-axis represents concentration in micromolar (µM), ranging from 0 to 70, and the x-axis shows time in hours up to 50 hours. The graph includes mean concentration and mean concentration plus 1, 2, and 3 standard deviations as separate lines.*

FDA Label Image

Sevo-fig9 (Sevo Fig9)

Line graph showing systemic vascular resistance (dyne·sec·cm⁻⁵) plotted against MAC level. The graph compares two conditions: Sevoflurane with oxygen (Sevo/O₂) and Sevoflurane with oxygen and nitrous oxide (Sevo/O₂/N₂O), illustrating decreasing vascular resistance with increasing MAC levels.*

FDA Label Image

Sevo-structure (Sevo Structure)

Chemical structure of Sevoflurane showing the central carbon atom bonded to fluorine atoms and an OCH2F group, representing the molecular arrangement of the active ingredient in Sojourn inhalation liquid.*

FDA Label Image

Sojourn100ml (Sojourn100ml)

Label for Sojourn Sevoflurane USP inhalation anesthetic liquid, 100 mL, by Piramal Critical Care Inc. The label includes storage instructions, dosing reference, barcode, and manufacturer contact information. The product is for prescription use only and made in the USA.*

FDA Label Image

Sojourn250ml (Sojourn250ml)

Label for Sojourn Sevoflurane USP inhalation anesthetic, 250 mL liquid for respiratory inhalation. The label includes the NDC 66794-012-25, states Rx only, and provides storage instructions at 20° to 25°C with allowed excursions. Manufactured by Piramal Critical Care Inc in Bethlehem, PA, USA. Contains a barcode and space for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.